期刊名称：PEDIATRIC INFECTIOUS DISEASE JOURNAL
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
The Pediatric Infectious Disease Journal, STRONG> is a peer-reviewed, multidisciplinary journal directed to physicians and other health care professionals who manage infectious diseases of childhood.
ISSN: 0891-3668
Instructions to Authors
Ethical/Legal Considerations
A submitted must be an original contribution not previously published (except as an abstract or preliminary report), must be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person liste as an author is excpected to have paricipated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published mansucripts, the final responsibility rests with teh authors, not the journal, its editors, or the publisher. Authors are encouraged to submit manuscripts online through the journal's Web site at http://pidj.edmgr.com/. See submission instructions under "On-line manuscript submission.
Patient anonymity and informed consent: It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors should mask patients' eyes or, if the eye area is the focus of the illustration, the patient's nose and mouth, and they should remove patients' names from figures unless written consent obtained from the patients is submitted with the manuscript.
Permissions: Authors must submit written permission from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the source.
Preparation of Manuscript
Manuscripts that do not adhere to the following instructions are returned to the corresponding author for technical revision before undergoing peer review.
Manuscript Submission
Authors are encouraged to submit their manuscript through the Web-based tracking system at . The site contains instructions and asvice on how to use the system, guidance on the creation/scanning and saving of eletronic art, and supporting documentaion. In addition to allowing authors to submit manuscripts on teh Web, the siste allows authors to follow the progression ot their mauscript throught the peer review process. Authors who do submit their mansucripts through the Web-based tracking system are asked not to send hard copies of the manuscript to the editorial office. They may, however, send to the editorial ofice any artwork, letters, or files that cannot be submitted electronically. Authors who are not yet ready for Web-based submission may mail their manuscripts with an electronic diskette to Chief editors, The Pediatric Infectious Disease Journal? University of Texas, Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Rm. F3.202 Dallas, TX 75390-9063; Phone: 214-648-2520; E-mail: pidj@UTSSouthwestern.edu. (Please see the checklist at the end of these Instructions before mailing manuscripts.) Address all inquiries regarding manuscripts not yet accepted or published to the Journal's editorial office. The editorial office acknowledges receipt of your manuscript and gives you a manuscript script number for references.
General format: Submit manuscripts in English in triplicate (one original and two copies) and printed on standard 81/2- ?11-inch (21- ?28-cm) paper with at least a 1-inch (2.5-cm) margin on all sides. Double space all copy, including legends, footnotes, tables, and references, and print on one side of the sheet only. If a manuscript is accepted for publication, the authors must then submit the final, accepted version of the manuscript on disk.
Title page: Title page must me submitted as a separate file if you choose the online system. Include on the title page: (a) complete manuscript title; (b) authors' full names, highest academic degrees, and affiliations; (c) name and address for correspondence, including telephone number, Fax number, and E-mail address; (d) address for reprints if different from that of corresponding author (indicate whether reprints are available); and (e) all sources of support, including pharmaceutical and industry support; that require acknowledgment. List three to five key words for indexing; (g) an abbreviated title of 35 characters or less used for the cover of the journal.
Structured abstract for Original Studies and Supplement Articles: Abstracts must be submitted as a separate file if you choose the online system. Limit the abstract to 250 words. Do not cite references in the abstract. Limit the use of abbreviations and acronyms. Use the following subheads: Background, Methods, Results, and Conclusions (others may be added as needed).
Unstructured abstract for Instructive Cases and Brief Reports: Abstract must be submitted as a separate file if you choose the online system. Limit the abstract to 60 words. It must be factual and comprehensive. Limit the use of abbreviations and acronyms, and avoid general statements (e.g. "the significance of the results is discussed").
Text: Organize the manuscript into four main headings, Introduction, Materials and Methods, Results, and Discussion. Define abbreviations at first mention in text. If a brand name is cited, supply the manufacturer's name and address (city and state/country).
Abbreviations: For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from Council of Science Editors, or other standard sources. Write out the full term for each abbreviation at its first use unless it is a standard unit of measure. Abbreviations are allowed only if used three times or more in text.
References: The authors are responsible for the accuracy of the references. Key the references (double-spaced) at the end of the manuscript. Cite the references in text in the order of appearance, including those references cited in tables and figure legends at the chronological citation of the tables and figures in text. Cite unpublished data, such as papers submitted but not yet accepted for publication or personal communications, in parentheses in the text. If there are more than six authors, name only the first three authors and then use et al. Refer to the List of Journals Indexed in Index Medicus for abbreviations of journal names, or access the list at http://www.nlm.nih.gov/tsd/serials/lji.html. Sample references are given below.
Journal article
1. Trujillo M, Correa N, Olsen K, et al. Cefprozil concentrations in middle ear fluid of children with acute otitis media. Pediatric Infect Dis J 2000;19:268-70.
Book chapter
2. Grose C. Bacterial myositis and pyomyositis. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 1998:704-8.
Entire book
3. Nelson JD, Bradley JS. Nelson's pocket book of pediatric antimicrobial therapy. 14th ed. Philadelphia: Lippincott Williams & Wilkins, 2000.
Proceedings
3. Harrigan PR, Dong W, Weber AE, et al. Clinical failure is associated with highly mutated RT and protease [Abstract I-115]. In: 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, September 24 to 27, 1998. Washington, DC: American Society for Microbiology, 1998. [if published]
4. Walmsley S, Walach C, Moses A, Becker M, Harrigan R. Can baseline genotype predict response to salvage therapy with nelfinavir? [Abstract 136]. Presented at the Sixth Conference on Retroviruses and Opportunistic Infections, Chicago, January 31 to February 4, 1999. [if unpublished]
Software
4. Epi Info [computer program]. Version 6. Atlanta: Centers for Disease Control and Prevention, 1994.
Online journals
5. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol [serial online]. January 1988;71:22-37. Available from: BRS Information Technologies, McLean, VA. Accessed December 15, 1990.
Database
6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute, 1996. Updated March 29, 1996.
World Wide Web
7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS web site]. June 1, 1996. Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997.
URL (uniform resource locator)
8. Kramer JM, Kramer K. [jmkramer@umich.edu], E-mail, March 6, 1996.
Figures: Cite figures consecutively in the online submission or in the text in the order in which they are discussed. Authors submitted manuscripts on paper should number figures and follow the rest of these figure instructions. Write the first author's last name, the figure number and figure part (1A, 1B, 1C), and an arrow to indicate the top edge of the figure on a label pasted to the back of each figure. Submit all artwork in triplicate in camera-ready form; illustrations should be glossy prints or high quality, laser-printed illustrations. Photocopies are unacceptable. Lettering should be large enough that it remains legible after figure reduction; typewritten or unprofessional lettering is unacceptable. Figure parts (A, B, C) may be left unlabeled (but clearly marked on back) for professional placement by the journal's printer.
Digital figures: Electronic art should be created/scanned and saved and submitted as a TIFF (tagged image file format), EPS (encapsulated PostScript) file, or a PPT (Power Point) file. Line art must have a resolution of at least 1200 dpi (dots per inch), and electronic photographs (radiographs, CT scans, and so on) and scanned images must have a resolution of at least 300 dpi. If fonts are used in the artwork, they must be converted to paths or outlines or they must be embedded in the files. Color images must be created/scanned and saved and submitted as CMYK files. All electronic art must be accompanied by high resolution laser prints of the images. Files can be submitted on a 3?inch high-density disk, a CD-ROM, or an Iomega Zip disk. Please note that artwork generated from office suite programs such Corel¦Draw and MS Word and artwork downloaded from the Internet (JPEG or GIFF files) cannot be used.
Figure legends: Includes legends must be submitted for all figures. They should be brief and specific, and they should appear on a separate manuscript page after the references. Legends should be part of the manuscript file on the disk. Use scale markers in the image for electron micrographs, and indicate the type of stain used.
Color figures: The journal accepts for publication color figures that enhances an article. Authors who submit color figures will receive an estimate of the cost for color reproduction. If they decide not to pay for color reproduction, they can request that the figures be converted to black and white at no charge.
Tables: Create tables using the table create and editing feature of your word processing software (e.g. Word, WordPerfect). Do not use Excel or comparable spreadsheet programs. Group all tables in a spear ate sheet file. Cite tables consecutively in the text, and number them in that order. Key each on a separate sheet, and include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviation not already defined in the text). Do not embed tables within the body of the manuscript. They should be self-explanatory and should supplement, rather than duplicate, the material in the text. In each table, the genus of each genus-species must be written out at its first appearance.
Brief Reports: Papers for this section should be no longer than 5-6 double-spaced typed manuscript pages (fewer than 1500 words), 10 references and 1 figure or table.
Style: Stedman's Medical Dictionary (27th edition) and Merriam Webster's Collegiate Dictionary (10th edition) should be used as standard references. Refer to drugs and therapeutic agents by their accepted generic or chemical names, and do not abbreviate them. Use code numbers only when a generic name is not yet available. Capitalize the trade names of drugs and place them in parentheses after the generic names. To comply with trademark law, include the name and location (city and state/country) of the manufacturer of any drug, supply, or equipment mentioned in the manuscript. Use the metric system to express units of measure and degrees Celsius or degrees Fahrenheit consistently throughout the manuscript to express temperatures, and use SI units rather than conventional units. Abbreviate "liter" in such forms as "3 units/l" and "5 ml"; write out when used alone (10 liters; 0.5-liter gavage). See also Day RA, ed. How to Write and Publish a Scientific Paper. 5th ed. Phoenix, AZ: The Oryx Press, 1998.
Address for manuscript submission: Send the manuscript with a cover letter to The Chief Editors, The Pediatric Infectious Disease Journal?/I>, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Rm. F3.202, Dallas, TX 75390-9063. Phone: 214-648-2520; Fax: 214-648-9091; E-mail address: pidj@UTSouthwestern.edu (please see the checklist at the end of these Instructions before mailing manuscripts). The editorial office will acknowledge receipt of your manuscript and will give you a manuscript number for reference. Address all inquiries regarding manuscripts not yet accepted or published to the journal's editorial office.
Review process: Manuscripts are sent for peer review with a request for prompt attention to them. The reviewers do not return the copies to the editorial office. The Chief Editors encourage authors to suggest names of reviewers who would provide an impartial assessment of their manuscript. If a manuscript is not accepted for publication, the manuscript is not returned to the authors.
Financial disclosure: In the cover letter, indicate all affiliations with or financial involvement in any organization or entity with a direct financial interest in the subject matter or materials of the research discussed in the manuscript (e.g. employment, consultancies, stock ownership). All such information will be held in confidence during the review process. Should the manuscript be accepted, the Chief Editors will discuss with the author the extent of disclosure appropriate for publication.
After Acceptance
Disk required for non-Web-based manuscripts: After a manuscript is accepted, any author who submitted the manuscript on paper in asked to send an electronic version of the final accepted manuscript, along with two printousts of the final revised manuscript. Electronic files should be submitted in a standard word processing format; Microsoft Word (or Corel WordPerfect) is preferred. Although conversions can be made from other word processing formats, the vagaries of the conversion process may introduce errors. Do not submit ASCII text files. Do not use automatic numbering or footnotes for references. The journal does not assume responsibility for errors in the conversion of customized software, newly released software, and special characters. Authors preparing manuscripts on Macintosh computers should not use the Fast Save option. Each submitted disk must be clearly labeled with the name of the author, item title, journal title, word processing program and version, and file name used. The disk should contain only one file--the final version of the accepted manuscript, including title page and figure legends.
Page proofs and corrections: Corresponding authors receive page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages and support documents (e.g., reprint order form) are sent to the corresponding author by E-mail. Complete instructions are provided with the E-mail for downloading and printing the files and for faxing the corrected page proofs to the publisher. Those authors without an E-mail address receive traditional page proofs. It is the author's responsibility to ensure that they are no errors in the proofs. Changes that have been made to conform to journal style stand if they do not alter the authors' meaning. Only the most critical changes to the accuracy of the content are made. Changes that are stylistic or are a reworking of previously accepted material are disallowed. The publisher reserve the content. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and returned within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs.
Copyright: It is necessary to Lippincott Williams and Wilkins to receive from each author of the manuscript a written signature on the copyright assignment form. This form will accompany proofs mailed from the publisher.
Reprints: Authors receive a reprint order form with the page proofs that includes reprint costs. Reprint order forms should be returned to Reprint Department, Lippincott Williams & Wilkins, 351 West Camden Street, Baltimore, MD 21201-2436. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprint Department with any questions.
Reprints: Authors will receive a reprint order form with the page proofs that includes reprint costs. Reprint order forms should be returned to Author Reprint Department, Lippincott Williams & Wilkins, 351 West Camden Street, Baltimore, MD 21201-2436. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprint Department with any questions.
Publisher's contact: Send corrected page proofs, color proofs, and any other related materials to Journal Production Editor, The Pediatric Infectious Disease Journal?/I>, Cadmus Professional Communications, 940 Elkridge Landing Road, Linthicum, MD 21090.
Manuscript Checklist (before submission) To top of page
- Three copies of complete manuscript (four if statistical data are included)
- Three sets of clearly labeled figures
- Cover letter
- Title page
- Abstract
- References double-spaced in US National Library of Medicine Style
- Corresponding author designated and E-mail address designated (in cover letter and on title page)
- Permission to reproduce copyrighted materials or signed patient consent forms
- Acknowledgments listed for grants and technical support
- Authorship Responsibility, Financial Disclosure, and Copyright Transfer form signed by each author
- Disk and high-quality print of electronic art
- Materials packed in extra-strength envelope
- Disk containing final version of manuscript after acceptance by editorial office
- Tables created using table software features
- Disk containing final version of manuscript after acceptance by editorial office
- Suggested reviewers
Editorial Board
Editorial Correspondence
Editor-in-Chief
John D. Nelson, M.D.
George H. McCracken Jr., M.D.
University of Texas
Southwestern Medical Center atDallas
5323 Harry Hines Blvd., Rm. F3.202
Dallas, TX 75390-9063
Phone: 214-648-2520
Fax: 214-648-2961
E-mail: pidj@UTSouthwestern.edu
|
